News Quantified

UBX – unity biotechnology, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Industry Veterans Announce Jupiter Bioventures, a Biotechnology Venture Foundry that Turns Novel Science into Transformational Companies [Yahoo! Finance]

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024

-2.5%

BEAT

Form SC 13G/A Unity Biotechnology, Filed by: Alyeska Investment Group, L.P.

Form 4 Unity Biotechnology, For: Nov 04 Filed by: Ghosh Anirvan

Form 4 Unity Biotechnology, For: Nov 04 Filed by: Nguyen Alexander Hieu

Form 4 Unity Biotechnology, For: Nov 04 Filed by: Sullivan Lynne Marie

Form 10-Q Unity Biotechnology, For: Sep 30

Top News Gainers

4/1 Form 4 Unity Biotechnology, For: Mar 30 Filed by: Marquess Dan 11.7%

2/1 Did Changing Sentiment Drive Unity Biotechnology's (NASDAQ:UBX) Share Price Down By 45%? [Yahoo! Finance News] 8.2%

10/31 Hedge Funds Have Never Been More Bullish On Brightcove Inc (BCOV) [Yahoo! Finance News] 7.9%

7/30 UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results 7.8%

12/12 Unity Biotechnology Inc (NASDAQ: UBX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock. 7.6%

11/6 Q3/2019 9/30/2019 EPS -0.510 ZacksConsensus -0.490 ActVsEst (0.020) - Miss 6.6%

5/23 UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences 5.3%

8/7 Q2/2019 6/30/2019 EPS -0.560 ZacksConsensus -0.440 ActVsEst (0.120) - Miss 5.3%

3/28 Unity Biotechnology Inc (NASDAQ: UBX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $6.50 price target on the stock. 3.5%

3/3 UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results 3.4%

Top News Decliners

3/31 UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101 -8.9%

2/25 UNITY Biotechnology Provides Pipeline and Business Updates -8.3%

9/23 Form 4 Unity Biotechnology, For: Sep 19 Filed by: Leonard Keith R -8.3%

6/18 UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee -8.2%

3/11 Q4/2019 12/31/2019 EPS -0.390 ZacksConsensus -0.540 ActVsEst 0.150 - Beat -6.5%

2/4 Unity Biotechnology Inc (NASDAQ: UBX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -6.2%

3/2 UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer -6.0%

1/28 Form CT ORDER Unity Biotechnology, -5.2%

2/11 Form SC 13G Unity Biotechnology, Filed by: David Nathaniel E -4.3%

10/24 UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting -4.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day